Understanding Neurodegenerative Diseases From the −Omics Perspective: Lessons Learnt
Annals of Neurology · 2026-03 · 99 (3) · 566-587
DOI: 10.1002/ana.78170 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of Neurology, online erschienen am 04.02.2026. Verfasst von Laura Ibanez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Proteomics, Genomics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
As the population ages, certain neurodegenerative diseases (NDs) are becoming a major health issue. For this reason, this review will focus on the most common ND with onset after 65 years old; Alzheimer's disease, Parkinson's disease, Lewy body dementia, and frontotemporal dementia. NDs are the results of multifactorial processes causing pleiotropic changes in molecular and protein networks linking a host of biological processes that lead to protein dysregulation and aggregation that ultimately leads to neurodegeneration. Genetic, transcriptomic, and proteomic studies have been instrumental to identify novel genes and proteins implicated on diseases that point to novel disease mechanism, as well as the identification of disease biomarkers. Here, we provide a review of the genomic, transcriptomic, and proteomic studies on ND so far, as well as future opportunities and challenges. ANN NEUROL 2026;99:566–587
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
- NeuroGenomics and Informatics Center, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
- Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
- Hope Center for Neurological Disorders, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
- The Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis, St. Louis, MO, USA.
- Department of Genetics, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
ORCID-Profile: Laura Ibanez, Carlos Cruchaga
Zitieren
APA
Ibanez, L., Pottier, C., Beric, A., Western, D., Ali, M., & Cruchaga, C. (2026). Understanding Neurodegenerative Diseases From the −Omics Perspective: Lessons Learnt. Annals of Neurology, 99(3), 566-587. https://doi.org/10.1002/ana.78170
Vancouver
Ibanez L, Pottier C, Beric A, Western D, Ali M, Cruchaga C. Understanding Neurodegenerative Diseases From the −Omics Perspective: Lessons Learnt. Annals of Neurology. 2026;99(3):566-587. doi:10.1002/ana.78170
BibTeX
@article{Ibanez2026,
author = {Ibanez, Laura and Pottier, Cyril and Beric, Aleksandra and Western, Daniel and Ali, Muhammad and Cruchaga, Carlos},
title = {Understanding Neurodegenerative Diseases From the −Omics Perspective: Lessons Learnt},
journal = {Annals of Neurology},
year = {2026},
volume = {99},
number = {3},
pages = {566--587},
doi = {10.1002/ana.78170}
}
EUVIMED